EU MDR  CER portafolio planning blog

Know the essential EU MDR portfolio planning requirements.

Portfolio planning is a key aspect of interfacing with your notified body. The upcoming EU MDR changes are significant, potentially impacting your device classification and the need for clinical data. Considering the overall timeline – including ISO 13485:2016 (March 2019) and MDSAP (if selling in Canada; Jan. 2019) – it will be difficult to get on notified bodies’ schedules. The time to plan is now.

You need to get information to your notified body to get on their schedule. The consolidation and disappearance of notified bodies has started. The notified bodies are sounding the alarm. Once there were 86 notified bodies and now there are less than 60 with a potential to go to less than 40. To make sure you have the reviews needed to keep your product on the market under the new regulation, you will need their review and the ones working with them to plan resources will get the priority.

This webinar will describe what information you need and the steps to creation of your portfolio plan. In addition, we will provide examples on how to communicate this to your notified body and what to expect as a response.

Access the on-demand webinar

We are passionate about your success. Tell us more about your regulatory and quality needs to learn about how we can help.

Book a Consultation


To display custom copy instead of global copy in this section, please go to Show Global Content for Bottom CTA? toggle in the "Contents" tab to the left, toggle it off, save, and then REFRESH the page editor, the custom text will then show up and ready to be edited.

Turning the global content back on will be the same process, go to the toggle and toggle it back on, save and refresh!